Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-10

Clinical Trial Update: A Phase III Study in Subjects With Mild to Moderate Psoriasis. [Phase 3]

View source ↗

Summary

A Phase III clinical trial update for subjects with mild to moderate psoriasis is reported, with phase and status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lipidor AB | Conditions: Mild to Moderate Psoriasis | Phase 3 | Status: UNKNOWN